Tag: metastatic cancer

Clinical safety of combined therapy of immune checkpoint inhibitors and Viscum album L. therapy in patients with advanced or metastatic cancer

This observational cohort study evaluated the clinical safety of combining immune checkpoint inhibitors (ICIs) with Viscum album L. (mistletoe) extract in patients with advanced or metastatic cancer. Sixteen patients were included, with nine receiving both ICI and mistletoe therapy. The study found no statistically significant increase in adverse events (67%

Read More »